This federal contract award, valued at $3,797.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a completion date of May 31, 2024.
Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, to provide a comprehensive range of medical commodities to support government agencies.
This contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis, reflecting Amerisourcebergen's strong position in the federal pharmaceutical supply market.
Generated 8/29/24, 9:50 AM